PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA (PHRMA)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2001–2007

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2007	—	2	1
2006	—	5	2
2005	—	3	1
2004	—	4	3
2003	—	5	4
2002	—	8	4
2001	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE HARBOUR GROUP	—	6
THE LOEFFLER GROUP	—	7
ML STRATEGIES, LLC	—	5
K&L GATES LLP	—	3
KATCHER VAUGHN & BAILEY COMMUNICATIONS	—	5
FONTHEIM INTERNATIONAL, LLC	—	3

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	15
SENATE	15
U.S. Trade Representative (USTR)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	18
Health Issues	Health Issues	11
Trade (domestic/foreign)	Trade (domestic/foreign)	8
Medicare/Medicaid	Medicare/Medicaid	8
Copyright/Patent/Trademark	Copyright/Patent/Trademark	6
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	5
Manufacturing	Manufacturing	4

Bills Explicitly Cited (21)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1038110th Congress

Access to Life-Saving Medicine Act

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: HR 1038

H.R. 1561110th Congress

Enhancing Drug Safety and Innovation Act of 2007

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: HR 1561

H.R. 1908110th Congress

Patent Reform Act of 2007

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: HR 1908

H.R. 4110th Congress

Medicare Prescription Drug Price Negotiation Act of 2007

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: HR 4

Show 17 more cited filings

S. 1145110th Congress

Patent Reform Act of 2007

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: S 1145

S. 242110th Congress

Pharmaceutical Market Access and Drug Safety Act of 2007

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: S 242

S. 3110th Congress

Medicare Prescription Drug Price Negotiation Act of 2007

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: S 3

S. 623110th Congress

Access to Life-Saving Medicine Act

2007 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

HR 1561, S 1082, S 623, HR 1038, S 242, S 3, HR 4, HR 1908, S 1145

Client expense: — · Firm income: $100,000

Matched citations: S 623

H.R. 1038110th Congress

Access to Life-Saving Medicine Act

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: H.R. 1038

H.R. 1561110th Congress

Enhancing Drug Safety and Innovation Act of 2007

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: H.R. 1561

H.R. 1908110th Congress

Patent Reform Act of 2007

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: H.R. 1908

H.R. 4110th Congress

Medicare Prescription Drug Price Negotiation Act of 2007

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: H.R. 4

S. 1145110th Congress

Patent Reform Act of 2007

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: S. 1145

S. 242110th Congress

Pharmaceutical Market Access and Drug Safety Act of 2007

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: S. 242

S. 3110th Congress

Medicare Prescription Drug Price Negotiation Act of 2007

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: S. 3

S. 623110th Congress

Access to Life-Saving Medicine Act

2007 · mid_year · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1561 (Enhancing Drug Safety and Innovation Act of 2007); S. 1082 (Prescription Drug USer Fee Act; S. 623 and H.R. 1038 (Access to Life Saving Medicine Act); S. 242 (Drug Importation); S. 3 and H.R. 4 (Drug Negotiation); H.R. 1908 and S. 1145 (Patent Reform Act of 2007)

Client expense: — · Firm income: $100,000

Matched citations: S. 623

S. 109109th Congress

Pharmaceutical Market Access Act of 2005

2006 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical issues, SCR 18; Pharmaceutical market access, S. 109, H.R. 328; Pharmaceutical importation, S. 184.

Client expense: — · Firm income: $100,000

Matched citations: S. 109

S. 184109th Congress

Safe IMPORT Act of 2005

2006 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical issues, SCR 18; Pharmaceutical market access, S. 109, H.R. 328; Pharmaceutical importation, S. 184.

Client expense: — · Firm income: $100,000

Matched citations: S. 184

S. 184109th Congress

Safe IMPORT Act of 2005

2006 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical importation, S.184

Client expense: — · Firm income: $100,000

Matched citations: S.184

S. 2507109th Congress

National Defense Authorization Act for Fiscal Year 2007

2006 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Patent Reform H.R. 2795; National Defense Authorization Act for Fiscal YEar 2007, H.R. 5122, S. 2507

Client expense: — · Firm income: $100,000

Matched citations: S. 2507

S. 2507109th Congress

National Defense Authorization Act for Fiscal Year 2007

2006 · year_end · Firm: THE LOEFFLER GROUP

Open original LDA filing ↗

Cited source text and reported amounts

National Defense Authorization Act for Fiscal Year 2007, H.R.5122, S.2507; Pharmaceutical and health care.

Client expense: — · Firm income: $100,000

Matched citations: S.2507

Source: Senate LDA

PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA (PHRMA) — Lobbying Disclosure | Poliscope